Lack of consensus identifies important areas for future clinical research: Advanced Prostate Cancer Consensus Conference (APCCC) 2019 findings
-
Published:2022-01
Issue:
Volume:160
Page:24-60
-
ISSN:0959-8049
-
Container-title:European Journal of Cancer
-
language:en
-
Short-container-title:European Journal of Cancer
Author:
Vogl Ursula M., Beer Tomasz M.ORCID, Davis Ian D.ORCID, Shore Neal D., Sweeney Christopher J., Ost Piet, Attard Gerhardt, Bossi Alberto, de Bono Johann, Drake Charles G., Efstathiou Eleni, Fanti Stefano, Fizazi Karim, Halabi Susan, James Nicolas, Mottet Nicolas, Padhani Anwar R.ORCID, Roach Mack, Rubin Mark, Sartor Oliver, Small Eric, Smith Matthew R., Soule Howard, Sydes Matthew R.ORCID, Tombal Bertrand, Omlin Aurelius, Gillessen Silke
Subject
Cancer Research,Oncology
Reference73 articles.
1. Management of patients with advanced prostate cancer: report of the advanced prostate cancer consensus conference 2019;Gillessen;Eur Urol,2020 2. In-depth analysis of the 2019 Advanced Prostate Cancer Consensus Conference (APCCC) – the importance of representation of medical specialty and geographic regions;Pratsinis;Eur Urol Open Sci,2021 3. Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial;James;Lancet,2016 4. Abiraterone for prostate cancer not previously treated with hormone therapy;James;N Engl J Med,2017 5. Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy;Messing;Lancet Oncol,2006
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|